M., Bugianesi, E., Rinella, M
,
Due to their weekly dosing schedule and greater mean weight loss seen in trials (15% for semaglutide and 21% for tirzepatide, compared to 8% with liraglutide), semaglutide and tirzepatide are more frequently prescribed than liraglutide for treatment of obesity [33,34,35]
Finalmente, el costo y accesibilidad favorecen claramente a los enfoques naturales, ya que los medicamentos GLP-1 pueden tener costos elevados sin cobertura de seguro, mientras que las modificaciones dietticas son generalmente ms econmicas y universalmente accesibles, aunque los costos varan segn la cobertura individual del seguro
Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: differences and similarities
Objective The goal of this study was to develop a predictive model for patient responsiveness to medications, here collectively called GLP-1 M, that include GLP-1 receptor agonists and dipeptidyl peptidase-4 (DPP4) inhibitors (that normally degrade endogenously-produced GLP-1)